CG
AMGN icon

Corundum Group’s Amgen AMGN Stock Holding History

Corundum Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
3,678
+41
+1% +$14K 0.4% 52
2026
Q1 		$1.28M Buy
3,637
+358
+11% +$128K 0.43% 50
2025
Q4 		$1.07M Sell
3,279
-247
-7% -$78.4K 0.36% 55
2025
Q3 		$995K Buy
3,526
+8
+0.2% +$2.32K 0.41% 53
2025
Q2 		$982K Buy
3,518
+1,570
+81% +$445K 0.43% 54
2025
Q1 		$607K Sell
1,948
-2,048
-51% -$605K 0.29% 68
2024
Q4 		$1.04M Buy
3,996
+2,030
+103% +$602K 0.39% 66
2024
Q3 		$633K Sell
1,966
-2,147
-52% -$702K 0.29% 66
2024
Q2 		$1.29M Buy
4,113
+2,166
+111% +$636K 0.5% 57
2024
Q1 		$554K Sell
1,947
-144
-7% -$42.1K 0.27% 68
2023
Q4 		$602K Buy
2,091
+123
+6% +$33.5K 0.3% 66
2023
Q3 		$529K Sell
1,968
-428
-18% -$107K 0.3% 66
2023
Q2 		$532K Sell
2,396
-1,818
-43% -$422K 0.27% 74
2023
Q1 		$1.02M Buy
4,214
+1,460
+53% +$358K 0.48% 63
2022
Q4 		$723K Sell
2,754
-1,322
-32% -$354K 0.41% 66
2022
Q3 		$919K Buy
4,076
+150
+4% +$36.4K 0.58% 42
2022
Q2 		$955K Buy
3,926
+311
+9% +$76.2K 0.65% 35
2022
Q1 		$874K Buy
3,615
+1,892
+110% +$435K 0.81% 44
2021
Q4 		$388K Buy
1,723
+480
+39% +$101K 0.25% 74
2021
Q3 		$264K Buy
1,243
+185
+17% +$42.6K 0.2% 86
2021
Q2 		$258K Sell
1,058
-21
-2% -$5.17K 0.17% 87
2021
Q1 		$268K Buy
1,079
+149
+16% +$35.6K 0.21% 76
2020
Q4 		$214K Buy
930
+31
+3% +$7.15K 0.18% 85
2020
Q3 		$228K Buy
+899
New +$223K 0.22% 71
2020
Q1 		– Sell
-973
Closed -$235K – 59
2019
Q4 		$235K Buy
+973
New +$214K 0.25% 62
2019
Q1 		– Sell
-2,790
Closed -$543K – 70
2018
Q4 		$543K Buy
+2,790
New +$544K 0.5% 46

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Corundum Group's AMGN Position: Q2 2026 in Review

Corundum Group increased its Amgen (AMGN) stake by 1.1% in Q2 2026, buying an estimated $14K and bringing the position to 3,678 shares worth $1.33M. The position accounts for 0.4% of the portfolio, ranked #52.

Corundum Group first reported a position in AMGN in Q4 2018 and has held it in 26 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Corundum Group held 3,678 shares of Amgen worth $1.33M as of Q2 2026.
  • Corundum Group bought 41 Amgen shares in Q2 2026, an estimated $14K.
  • Amgen made up 0.4% of Corundum Group's portfolio in Q2 2026, its #52 holding.
  • Corundum Group first reported a position in Amgen in Q4 2018 and has held it in 26 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Corundum Group's 13F filing for Q2 2026, filed 7 Aug 2026.